Scientific publications for LFB
LFB SIGNS AGREEMENT WITH XENOTHERA TO MANUFACTURE FIRST CLINICAL BATCH OF XENOTHERA'S XAV-19 FOR THE TREATMENT OF CORONAVIRUS INFECTIONS INCLUDING COVID-19
GLOBAL PLASMA LEADERS COLLABORATE TO ACCELERATE DEVELOPMENT OF POTENTIAL COVID-19 HYPERIMMUNE THERAPY
LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa
COVID-19: LFB and its employees are mobilized to provide medicines for patients.
From all of us at LFB, we wish you happiness and health for the New Year!
LFB's commitment to patients
Discover the LFB Arras plant under construction - September 2019